The incidence rate of vulvar cancer is low and the management is complex,especially in patients with locally advanced vulvar cancer. In recent years,researches on neoadjuvant chemotherapy for vulvar cancer have gradually increased. Through neoadjuvant chemotherapy,tumor lesions can be reduced to avoid surgical removal of organs such as the urethra and anus,preserving organ function,and improving patient quality of life. However,there are still relatively few studies at present,and most of them are retrospective studies. Further research is still needed to evaluate the therapeutic effect and neoadjuvant chemotherapy regimen.
DENG Hao, WANG Jian-liu.
Neoadjuvant chemotherapy in vulvar cancer. [J]. Chinese Journal of Practical Gynecology and Obstetrics. 2023, 39(7): 698-701 https://doi.org/10.19538/j.fk2023070106